These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27513948)

  • 21. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
    Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic and theoretical comprehension of diverse rate laws and reactivity gaps in Coriolus hirsutus laccase-catalyzed oxidation of acido and cyclometalated Ru(II) complexes.
    Kurzeev SA; Vilesov AS; Fedorova TV; Stepanova EV; Koroleva OV; Bukh C; Bjerrum MJ; Kurnikov IV; Ryabov AD
    Biochemistry; 2009 Jun; 48(21):4519-27. PubMed ID: 19351176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
    Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
    Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
    Manerba M; Di Ianni L; Fiume L; Roberti M; Recanatini M; Di Stefano G
    Eur J Pharm Sci; 2015 Jul; 74():95-102. PubMed ID: 25930121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer activity of two novel ruthenium compounds in gastric cancer cells.
    Ramírez-Rivera S; Pizarro S; Gallardo M; Gajardo F; Delgadillo A; De La Fuente-Ortega E; MacDonnell FM; Bernal G
    Life Sci; 2018 Nov; 213():57-65. PubMed ID: 30326218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
    Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
    Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
    Vettraino M; Manerba M; Govoni M; Di Stefano G
    Anticancer Drugs; 2013 Sep; 24(8):862-70. PubMed ID: 23797802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors.
    Poli G; Granchi C; Aissaoui M; Minutolo F; Tuccinardi T
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29236080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
    Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
    J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ru/Fe bimetallic complexes: Synthesis, characterization, cytotoxicity and study of their interactions with DNA/HSA and human topoisomerase IB.
    Takarada JE; Guedes APM; Correa RS; Silveira-Lacerda EP; Castelli S; Iacovelli F; Deflon VM; Batista AA; Desideri A
    Arch Biochem Biophys; 2017 Dec; 636():28-41. PubMed ID: 29107586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand.
    Koiri RK; Trigun SK; Mishra L; Pandey K; Dixit D; Dubey SK
    Invest New Drugs; 2009 Dec; 27(6):503-16. PubMed ID: 19043664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models.
    Huang H; Zhang P; Chen H; Ji L; Chao H
    Chemistry; 2015 Jan; 21(2):715-25. PubMed ID: 25388328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
    Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
    Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
    J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.
    Fetzer L; Boff B; Ali M; Xiangjun M; Collin JP; Sirlin C; Gaiddon C; Pfeffer M
    Dalton Trans; 2011 Sep; 40(35):8869-78. PubMed ID: 21837342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potent ruthenium(II) antitumor complex bearing a lipophilic levonorgestrel group.
    Ruiz J; Rodríguez V; Cutillas N; Espinosa A; Hannon MJ
    Inorg Chem; 2011 Sep; 50(18):9164-71. PubMed ID: 21830785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metal Cu(II) and Zn(II) bipyridyls as inhibitors of lactate dehydrogenase.
    Koiri RK; Trigun SK; Dubey SK; Singh S; Mishra L
    Biometals; 2008 Apr; 21(2):117-26. PubMed ID: 17541766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
    Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
    J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase IIα poisoning and DNA double-strand breaking by chiral ruthenium(ii) complexes containing 2-furanyl-imidazo[4,5-f][1,10]phenanthroline derivatives.
    Qian C; Wu J; Ji L; Chao H
    Dalton Trans; 2016 Jun; 45(26):10546-55. PubMed ID: 27226117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.